Richard Osborne Day

87PUBLICATIONS
210CO-AUTHORS
Major global burdens of diseaseGene and molecular therapyMolecular medicinePatient safetyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (87)

|Aug 17, 2026
Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes.

|May 15, 2026
Ten-Year Public Expenditure Savings Associated with TNF Inhibitor Biosimilars under Australia's Pharmaceutical Benefits Scheme.

|May 11, 2026
Continuous Subcutaneous Ketamine Infusion May Induce Tacrolimus and Sirolimus Clearance: A Case Report.

|Mar 20, 2026
Achieving effective medicines governance: guiding principles for the roles and responsibilities of Medicines and Therapeutics Committees in Australian hospitals.

Lisa Crisp, Richard Day, Anita Shutt

|Feb 25, 2026
Efficacy and Harms of Opioid Analgesics for Acute Pain: Overview of Systematic Reviews and Meta-analyses.

Stephanie Mathieson, Joshua R Zadro, Sujita W Narayan

|Dec 04, 2025
Equity and quality use of medicines in people who present to the Psychiatric Alcohol and Non-Prescription Drug Assessment Unit.

Jana Stojanova, Elysse Bo Kwan Choy, Jonathan Brett

Pageof 15

Frequent Collaborators

23 joint publications

Sophie Stocker

12 joint publications

Jane Ellen Carland

11 joint publications

Melissa T Baysari

10 joint publications

Matthew J Coleshill